Eli Ben‐Chetrit
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Use and Resistance 6
-
- Antibiotic Resistance in Bacteria 9
- Co-authors
- Yonit Wiener‐WellYackov BerkunEldad Ben‐ChetritAvraham Ben‐ChetritMarc V. AssousAmos M. YinnonHedi OrbachMatan J. Cohen
- Journals
- International Journal of Clinical Practice (4 papers)European Journal of Clinical Microbiology & Infectious Diseases (3 papers)Clinical Infectious Diseases (2 papers)Frontiers in Immunology (2 papers)Seminars in Arthritis and Rheumatism (2 papers)
- Partner nations
- IsraelUnited StatesSwitzerland
In The Last Decade
Eli Ben‐Chetrit
76 papers receiving 962 citations
Peers
Comparison fields: 5 of 113
- Molecular Medicine 95
- Applied Microbiology and Biotechnology 36
- Nephrology 112
- Infectious Diseases 164
- Rheumatology 123
Countries citing papers authored by Eli Ben‐Chetrit
This map shows the geographic impact of Eli Ben‐Chetrit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli Ben‐Chetrit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Ben‐Chetrit more than expected).
Fields of papers citing papers by Eli Ben‐Chetrit
This network shows the impact of papers produced by Eli Ben‐Chetrit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli Ben‐Chetrit. The network helps show where Eli Ben‐Chetrit may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eli Ben‐Chetrit, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 9 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 4 | |
| 5 | 2021 | 0 | |
| 6 | 2021 | 5 | |
| 7 | 2021 | 0 | |
| 8 | 2019 | 13 | |
| 9 | 2019 | 29 | |
| 10 | 2017 | 36 | |
| 11 | 2016 | 18 | |
| 12 | 2016 | 16 | |
| 13 | 2014 | 37 | |
| 14 | 2014 | 16 | |
| 15 | 2013 | 14 | |
| 16 | 2012 | 3 | |
| 17 | 2010 | 48 | |
| 18 | 2007 | 22 | |
| 19 | 2002 | 27 | |
| 20 | Familial Mediterranean fever clinical and genetic features in Druzes and in Iraqi Jews: a preliminary study. | 1998 | 26 |
About Eli Ben‐Chetrit
Eli Ben‐Chetrit is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Microbiology, Clinical Biochemistry and Infectious Diseases, having authored 80 papers that have together received 989 indexed citations. Recurring topics across this work include Inflammasome and immune disorders (17 papers), Antibiotic Resistance in Bacteria (9 papers), interferon and immune responses (8 papers), Bacterial Identification and Susceptibility Testing (8 papers), COVID-19 Clinical Research Studies (7 papers), Streptococcal Infections and Treatments (6 papers), Antibiotic Use and Resistance (6 papers) and Pneumonia and Respiratory Infections (4 papers). The work is most often cited by research in Molecular Medicine (95 citations), Applied Microbiology and Biotechnology (36 citations), Nephrology (112 citations), Infectious Diseases (164 citations) and Rheumatology (123 citations). Eli Ben‐Chetrit has collaborated with scholars based in Israel, United States and Switzerland. Frequent co-authors include Yonit Wiener‐Well, Yackov Berkun, Eldad Ben‐Chetrit, Avraham Ben‐Chetrit, Marc V. Assous, Amos M. Yinnon, Hedi Orbach, Matan J. Cohen, M Eliakim and Dana G. Wolf. Their work appears in journals such as International Journal of Clinical Practice, European Journal of Clinical Microbiology & Infectious Diseases, Clinical Infectious Diseases, Frontiers in Immunology and Seminars in Arthritis and Rheumatism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.